China Europe style for Clindamycin HCL 21462-39-5 - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore manufacturers and suppliers

Europe style for Clindamycin HCL 21462-39-5 - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore

Short Description:

Product Detail

Product Tags

Feedback (2)

Our corporation insists all along the quality policy of "product top quality is base of organization survival; purchaser pleasure will be the staring point and ending of an company; persistent improvement is eternal pursuit of staff" plus the consistent purpose of "reputation very first, purchaser first" for 129499-78-1, S-Acetyl-L-Glutathione 3054-47-5, Tofacitinib citrate, Our intention should be to assist customers comprehend their goals. We have been creating terrific endeavours to obtain this win-win circumstance and sincerely welcome you to definitely join us!

Europe style for Clindamycin HCL 21462-39-5 - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 100kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods

Tofacitinib citrate

Introduction

Tofacitinib, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Tofacitinib citrate is used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate.

Tofacitinib citrate is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs.

Specification (in house)

Item	Specification
Appearance	White or off-white crystalline powder
Identification	IR, HPLC
Water	≤1.5%
Related Substances	TOFA 06 ≤0.15%
	Tofacitinib trans isomer ≤0.15%
	Tofacitinib dehydrogenated ≤0.15%
	Each unknown impurity ≤0.10%
	Total Impurities: ≤1.0%
Residual Solvents	Ethanol ≤5000ppm
	Benzene ≤2ppm
	Toluene ≤890ppm
	Chlroroethane ≤1000ppm
	N,N-Dimethylformamide ≤800ppm
	Palladium ≤10ppm
	Dichloromethane ≤600ppm
Sulphated ash	≤0.1%
Heavy Metal	≤10ppm
Chrial HPLC	3S, 4S tofacitinib ≤0.15%
Chrial HPLC	Assay (on anhydrous basis) 98.0-102.0%

Product detail pictures:

Related Product Guide:

With dependable high-quality method, fantastic standing and ideal purchaser assistance, the series of products produced by our firm are exported to many countries and regions for Europe style for Clindamycin HCL 21462-39-5 - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore , The product will supply to all over the world, such as: Armenia, Islamabad, Bandung, We are introduced as a one of the growing manufacture supplier and export of our products. We have a team of dedicated trained professional who take care the quality and timely supply. If you are looking for Good Quality at a good price and timely delivery. Do contact us.

1397-89-3